https://www.asm.org/modules/mod_image_show_gk4/cache/mSphere Direct herogk-is-651.pnglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Microbe Submit Abstract Slidegk-is-651.jpglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Science Advisor Slidegk-is-651.jpglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Amy Chang Bannergk-is-651.jpglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Governance Hero Bannergk-is-651.jpglink
0 1 2 3 4
Progress bar
08-12-2016mSphere Direct
08-12-2016Science Advisor
08-12-2016Amy Chang
08-12-2016Nominate
Become a member today!
JOIN/RENEW
Submit to an ASM Journal
SUBMIT
Attend ASM Biothreat Meeting
REGISTER

subbarao kantaDr. Subbarao’s research is focused on newly emerging viral diseases of global importance: pandemic influenza and the severe acute respiratory syndrome (SARS). The goal of the research program is to develop vaccines; this bench-to-clinic program includes investigations that range from pathogenesis to applied vaccinology. The influenza program addresses questions of viral antigenicity including evaluation of genetic and antigenic relatedness and cross-protection between animal influenza viruses, pathogenesis, host responses, and vaccine development. Pathogenesis and host responses to vaccines and immunoprophylaxis strategies are evaluated in animal models. Preclinical and clinical evaluations are undertaken for vaccines generated from viruses with site-specific mutations generated by plasmid-based reverse genetics.

TPL_asm2013_SEARCH

91148